From August 11 to September 22, 2004, call toll-free to join your colleagues for a stimulating, live exchange of ideas on the challenges of managing hypertension in 2004.

Program Description
Each 1-hour interactive teleconference includes a short introduction, a 25- to 30-minute presentation, and a 20-minute question-and-answer session with a member of the faculty. Participants are encouraged to ask questions to ensure a lively discussion.

This Web site contains faculty names and affiliations and the teleconference schedule from August 11 to September 22, 2004. To register, please follow the instructions found below. Five days prior to your scheduled teleconference you will receive a CME workbook containing information regarding your participation in the program, or you can download a copy by clicking on Program Workbook.

To Register
Review the Teleconference Schedule to select a date and time convenient for you. Click on Registration to fill out the registration form.

Target Audience Primary care physicians

Goal To provide primary care physicians with current data and expert commentary on achieving goal blood pressure levels in clinical practice

Learning Objectives
Upon completion of this activity, participants should be better able to:
• Describe the importance of systolic blood pressure in cardiovascular morbidity and mortality
• State current goal blood pressure levels for patients with and without diabetes
• Discuss the results of recent randomized studies, such as the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial, and their relevance to clinical practice
• Identify effective combinations of antihypertensive agents to achieve goal blood pressure levels

Faculty
Gerald B. Appel, MD
John M. Flack, MD, MPH
Richard H. Grimm, Jr, MD, PhD, MPH

How to Receive Credit
To qualify for CME credit, you must participate for the entire teleconference, answer the self-assessment questions, and submit the evaluation form. The estimated time to complete the entire activity is about 1 hour.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of New York Medical College (NYMC) and QD Healthcare Group. NYMC is accredited by the ACCME to provide continuing medical education for physicians. NYMC designates this activity for a maximum of 1 category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those credit(s) that he/she actually spent in the educational activity.

All faculty participating in continuing education activities are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in their presentation, whether or not support has been provided for the relevant activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation. Complete disclosures will be provided at the time of the activity.

The providers of this program have waived the processing fees.

We gratefully acknowledge Pfizer Inc for its generous support of this activity

Receive a FREE medical resource for your participation.